A prospective multicenter study of patients treated with molecular target therapy for hepatocellular carcinoma

A prospective multicenter study of patients treated with molecular target therapy for hepatocellular carcinoma - Molecular target therapy for hepatocellular carcinoma: a prospective multicenter study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010085

Enrollment

300

Registered

2013-03-01

Start date

2012-12-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with unresectable hepatocellular carcinoma and indicated for molecular target therapy

Exclusion criteria

Exclusion criteria: (1) Patients who do not give informed consent (2) Patients who is not thought to be eligible for participation in this study by researchers

Design outcomes

Primary

Measure	Time frame
Antitumor effects and occurrence of adverse events in molecular target therapy for hepatocellular carcinoma	—

Countries

Japan

Contacts

Public ContactKazuki Maesaka

Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology

k.maesaka@gh.med.osaka-u.ac.jp06-6879-3621

Outcome results